First Line Therapy for High Risk Acute GVHD
Conditions: aGVHD; Stem Cell Transplant Complications Interventions: Drug: Ruxolitinib; Drug: Corticosteroid Sponsor: Chinese PLA General Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials